CIK 0001551152
- Large accelerated filer
AbbVie Inc.
Sign in to watch- Ticker
- ABBV
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320375147
- Phone
- +1 847-932-7900
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,925,738
- in 1 filing
Net −$11,925,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Thakkar Roopal EVP, R&D and CSO | Shares withheld for taxes | −8,037 | $232.08 | $1.9M | 52,376 |
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +6,015 | 48,291 | ||
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +2,138 | 50,429 | ||
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +3,346 | 53,775 | ||
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +6,638 | 60,413 | ||
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award · Option (Right to buy) | +21,937 | 21,937 | ||
| 2025-02-28 | Thakkar Roopal EVP, R&D and CSO | Shares withheld for taxes | −4,678 | $205.02 | $959K | 42,276 |
| 2025-02-13 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +3,595 | 39,994 | ||
| 2025-02-13 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +1,474 | 41,468 | ||
| 2025-02-13 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +2,138 | 43,606 | ||
| 2025-02-13 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +3,348 | 46,954 | ||
| 2025-02-13 | Thakkar Roopal EVP, R&D and CSO | Grant or award · Option (Right to buy) | +25,000 | 25,000 | ||
| 2024-02-28 | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Shares withheld for taxes | −4,914 | $178.99 | $880K | 23,259 |
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +5,900 | 36,125 | ||
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +1,572 | 37,697 | ||
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +1,476 | 39,173 | ||
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +2,140 | 41,313 | ||
| 2024-02-15 | Thakkar Roopal EVP, R&D and CSO | Grant or award · Option (Right to buy) | +13,868 | 13,868 | ||
| 2024-02-15 | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Grant or award | +8,022 | 18,399 | ||
| 2024-02-15 | Thakkar Roopal SVP, CMO, GLOBAL THERAPEUTICS | Grant or award | +2,138 | 20,537 |
Page 1 of 2 · 23 trades